Literature DB >> 33440192

Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.

Monica M Sauter1, Curtis R Brandt2.   

Abstract

The goal of this study was to determine the expression and distribution of the host restriction factors (RFs) TRIM5α and TRIM11 in non-human primate (NHP) neural retina tissue and the human Muller cell line MIO-M1. In addition, experiments were performed to determine the effect of TRIM5α and TRIM11 knockdown on FIVGFP transduction of MIO-M1 cells with the goal of devising strategies to increase the efficiency of lentiviral (LV) gene delivery. Immunofluorescence (IF) studies indicated that TRIM5α and TRIM11 were localized predominantly in nuclei within the outer nuclear layer (ONL) and inner nuclear layer (INL) of NHP retina tissue. Double label IF indicated that TRIM5α and TRIM11 were localized to some of the retinal Muller cell nuclei. MIO-M1 cells expressed TRIM5α predominantly in the nucleus and TRIM11 primarily in the cytosol. FIVGFP transduction efficiency was significantly increased, at 4 and 7 days post transduction, in TRIM5α and TRIM11 knockdown clones (KD) compared to WT MIO-M1 cells. In addition, pretreatment with the proteasome inhibitor MG132 increased the transduction efficiency of FIVGFP in WT MIO-M1 cells. The nuclear translocation of NF-κB (p65), at 72 h post FIVGFP transduction, was enhanced in TRIM5α and TRIM11 KD clones. The expression of TRIM5α and TRIM11 in macaque neural retina tissue and MIO-M1 cells indicate the presence of these RFs in NHP retina and human Muller cells. Our data indicate that even partial knockdown of TRIM5α or TRIM11, or a short proteasome inhibitor pretreatment, can increase the transduction efficiency of a LV vector.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene therapy; Muller cells; Proteasome inhibitor; Retina; TRIM11; TRIM5α; Viral vectors

Mesh:

Substances:

Year:  2021        PMID: 33440192      PMCID: PMC7946771          DOI: 10.1016/j.exer.2021.108436

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  51 in total

1.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

Review 2.  Seeing the Light after 25 Years of Retinal Gene Therapy.

Authors:  Ivana Trapani; Alberto Auricchio
Journal:  Trends Mol Med       Date:  2018-07-05       Impact factor: 11.951

3.  Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection.

Authors:  Cindy M Danielson; Gianguido C Cianci; Thomas J Hope
Journal:  Traffic       Date:  2012-06-19       Impact factor: 6.215

4.  Viral Vector Effects on Exoenzyme C3 Transferase-Mediated Actin Disruption and on Outflow Facility.

Authors:  Sarah R Slauson; Donna M Peters; Marie K Schwinn; Paul L Kaufman; B'Ann T Gabelt; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

Review 5.  Feline immunodeficiency virus-based lentiviral vectors.

Authors:  Dyana T Saenz; Román Barraza; Nils Loewen; Wulin Teo; Eric M Poeschla
Journal:  Cold Spring Harb Protoc       Date:  2012-01-01

Review 6.  Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.

Authors:  Tuyen Ong; Mark E Pennesi; David G Birch; Byron L Lam; Stephen H Tsang
Journal:  Pharm Res       Date:  2019-01-07       Impact factor: 4.200

Review 7.  Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.

Authors:  Ashok Kumar; Rajeev K Pandey; Lindsay J Miller; Pawan K Singh; Mamta Kanwar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling.

Authors:  Josefina Lascano; Pradeep D Uchil; Walther Mothes; Jeremy Luban
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

9.  The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.

Authors:  Ting Yuan; Weitong Yao; Fang Huang; Binlian Sun; Rongge Yang
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

10.  Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork.

Authors:  Zeynep Aktas; Hongyu Rao; Sarah R Slauson; B'Ann T Gabelt; Inna V Larsen; Rachael T C Sheridan; Leonie Herrnberger; Ernst R Tamm; Paul L Kaufman; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.